期刊文献+

镁掺杂纳米羟基磷灰石的制备及其在载药方面的应用 被引量:11

Preparation and Drug Delivery Properties of Mg-Doped Hydroxyapatite Nanoparticles
下载PDF
导出
摘要 通过逐步沉淀反应一锅法制备了一系列不同含量的镁掺杂纳米羟基磷灰石。通过硝酸镁、硝酸钙不同的投料物质的量比调控纳米颗粒的形态和尺寸。通过透射电子显微镜(TEM)、X射线衍射(XRD)等分析手段对镁掺杂纳米羟基磷灰石进行物理化学性能表征,用MTT法评价其体外细胞毒性。研究结果表明:镁掺杂纳米羟基磷灰石呈现束状纳米纤维形态、比表面积大、细胞毒性较低;将其作为载体负载抗癌药物顺铂,具有很好的载药能力,载药量可达54%,该载药纳米颗粒还具备缓释特性(72 h释药量达到41.72%)和很好抑制癌细胞生长的效果。 Magnesium-doped hydroxyapatites nanoparticles(Mg-HAs)with different feeding molar ratios were synthesized by step precipitation reaction and one pot reaction.The morphology and size of the Mg-HAs were controlled by different feeding molar ratio of magnesium nitrate and calcium nitrate.The Mg-HAs were characterized by transmission electron microscope,X-ray diffraction,et al.MTT method was used to evaluated in vitro cytotoxicity of the Mg-HAs.Results show that the synthesized Mg-HAs had the frame with fiber like structure,high specific surface area and low cell cytotoxicity.Mg-HAs as drug carrier material and cisplatin(cDDP)as a model drug were investigated,and the max loading rate was 54.84%.The drug loading Mg-HAs also have release properties(the releasing rate is 41.72%after 72 h),and a better inhibitory effect on cancer cells.
作者 马晓雨 刘永佳 朱邦尚 MA Xiao-Yu;LIU Yong-Jia;ZHU Bang-Shang(School of Chemistry and Chemical Engineering,Shanghai Jiao Tong University,Shanghai 200240,China;Instrumental Analysis Center,Shanghai Jiao Tong University,Shanghai 200240,China)
出处 《无机化学学报》 SCIE CAS CSCD 北大核心 2018年第5期917-924,共8页 Chinese Journal of Inorganic Chemistry
基金 国家自然科学基金(No.51373099)资助项目
关键词 镁掺杂纳米羟基磷灰石 逐步反应法 顺铂 载药 magnesium doped hydroxyapatite step reaction cisplatin drug loading
  • 相关文献

参考文献1

二级参考文献14

  • 1杨为中,周大利,尹光福,尹绍雅,郑昌琼.磷酸钙/BMP复合生物活性骨水泥水化性能及诱导成骨特性研究[J].无机材料学报,2005,20(5):1174-1180. 被引量:10
  • 2季晓风,丛宪玲,杨晓玉,段德生.人骨形成蛋白纳米微粒的制备与生物活性鉴定[J].中国实验诊断学,2006,10(3):261-263. 被引量:2
  • 3Yao A H,Ai F R,Liu Xin,et al.Preparation of hollow hydroxyapatite microspheres by the conversion of borate glass at near room temperature.Mater.Res.Bull.,2010,45(1):25-28.
  • 4Tanaka H,Mizokami H,Shiigi E,et al.Effects of basic fibroblast growth factor on the repair of large osteochondral defects of articular cartilage in rabbits:dose-response effects and long-term outcomes.Tissue Eng.,2004,10(3/4):633-641.
  • 5Hu Y Y,Zhang C,Zhang S M,et al.Development of a porous poly(L-lactic acid)/hydroxyapatite/ collagen scaffold as a BMP delivery system and its use in healing canine segmental bone defect.J.Biomed.Mater.Res.A,2003,67(2):591-598.
  • 6Nakashima M,Reddi A H.The application of bone morphogenetic proteins to dental tissue engineering.Nat.Biotechnol.,2003,21(9):1025-1032.
  • 7Davies S D,Ochs M W.Bone morphogenetic proteins in craniomaxillofacial surgery.Oral Maxillofac Surg.Clin.North Am.,2010,22(1):17-31.
  • 8Dimitriou R,Giannoudis P V.Discovery and development of BMPs.Injury,2005,36(3):S28-S33.
  • 9Fei Z Q,Hu Y Y,Wu D C,et al.Preparation and property of a novel graft composite consisting of rhBMP-2 loaded PLGA microspheres and calcium phosphate cement.J.Mater.Sci:Mater.Med.,2008,19(3):1109-1116.
  • 10Liu H N,Yazici H L,Ergun C D,et al.An in vitro evalution of the Ca/P ratio for the cytocompatibility of nano-to-micron particulate calcium phosphates for bone regeneration.Acta Biomater.,2008,4(5):1472-1479.

共引文献10

同被引文献86

引证文献11

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部